|
Bio-Techne corporation
human igf-ii/igf2 antibody Human Igf Ii/Igf2 Antibody, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/bio-techne+corporation___mab292?v=Bio-Techne+corporation Average 94 stars, based on 1 article reviews
human igf-ii/igf2 antibody - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Boster Bio
anti zbp1 Anti Zbp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc13006297-220-20-27?v=Boster+Bio Average 93 stars, based on 1 article reviews
anti zbp1 - by Bioz Stars,
2026-07
93/100 stars
|
Buy from Supplier |
|
Boster Bio
primary antibodies against α sma Primary Antibodies Against α Sma, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pm41606740-82-1-7?v=Boster+Bio Average 94 stars, based on 1 article reviews
primary antibodies against α sma - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Boster Bio
igf2 ![]() Igf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc08303261-9-0-10?v=Boster+Bio Average 90 stars, based on 1 article reviews
igf2 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Boster Bio
primary antibodies against imp1 ![]() Primary Antibodies Against Imp1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pm37958584-239-0-24?v=Boster+Bio Average 94 stars, based on 1 article reviews
primary antibodies against imp1 - by Bioz Stars,
2026-07
94/100 stars
|
Buy from Supplier |
|
Boster Bio
igf 2r ![]() Igf 2r, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc03503720-123-8-15?v=Boster+Bio Average 90 stars, based on 1 article reviews
igf 2r - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Kirin Holdings Company Limited
anti-igf2 neutralizing antibody ![]() Anti Igf2 Neutralizing Antibody, supplied by Kirin Holdings Company Limited, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/10__2147_slash_ott__s211043-30-0-7?v=Kirin+Holdings+Company+Limited Average 90 stars, based on 1 article reviews
anti-igf2 neutralizing antibody - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
MedImmune llc
monoclonal antibodies against igf-1 and igf-2 ![]() Monoclonal Antibodies Against Igf 1 And Igf 2, supplied by MedImmune llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc08892134-105-6-11?v=MedImmune+llc Average 90 stars, based on 1 article reviews
monoclonal antibodies against igf-1 and igf-2 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
GeneTex
anti-igf2 gtx60630 ![]() Anti Igf2 Gtx60630, supplied by GeneTex, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc06441876-80-28-29?v=GeneTex Average 90 stars, based on 1 article reviews
anti-igf2 gtx60630 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Boster Bio
rabbit anti igf2 ![]() Rabbit Anti Igf2, supplied by Boster Bio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pm32882328-109-8-11?v=Boster+Bio Average 90 stars, based on 1 article reviews
rabbit anti igf2 - by Bioz Stars,
2026-07
90/100 stars
|
Buy from Supplier |
|
Creative Biolabs
anti human muc1 therapeutic antibody fab fragment ![]() Anti Human Muc1 Therapeutic Antibody Fab Fragment, supplied by Creative Biolabs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc13020000-78-0-10?v=Creative+Biolabs Average 86 stars, based on 1 article reviews
anti human muc1 therapeutic antibody fab fragment - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
|
Signalway Antibody
igf2 ![]() Igf2, supplied by Signalway Antibody, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/anti+igf2/pmc12613509-168-27-28?v=Signalway+Antibody Average 86 stars, based on 1 article reviews
igf2 - by Bioz Stars,
2026-07
86/100 stars
|
Buy from Supplier |
Image Search Results
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Primers sequences for qPCR.
Article Snippet:
Techniques: Amplification
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Antibodies used for Western blot.
Article Snippet:
Techniques: Western Blot
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Transcription factors and autoantigens transcripts in the whole thymus. Complementary DNA obtained from mock- and CV-B4-infected thymuses ( n = 5–7), harvested at different time-points, was submitted to quantification of Aire , Fezf2 , Igf2, and Myo7 transcripts by qPCR. Transcripts levels were normalized to those of Oaz1. Relative gene expression in CV-B4 E2- vs. mock-infected thymuses was calculated, as described in , and expressed as 100 × mean 2 −ΔΔCt values ± SD. The unpaired t -test was used for statistical analysis. ** p < 0.01. Mock (●) mock-infected thymuses harvested at different time points, from fetuses at day 17 of gestation (day 17G), and newborns at day 1 and day 5 from birth. CV-B4 10G (▼): thymus harvested from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (♦): thymus harvested from mice born to dams inoculated with CV-B4 at day 17 of gestation.
Article Snippet:
Techniques: Immunopeptidomics, Infection, Gene Expression
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Transcription factors and autoantigens transcripts in enriched thymic epithelial cells. Whole thymuses were harvested, at different time-points, from offspring born to mock- and CV-B4-infected dams. Thymuses from fetuses or neonates of the same litter ( n = 5–12) were pooled and subjected to TECs isolation. Transcripts levels for Aire , Fezf2 , Igf2, and Myo7 , in enriched TECs, were determined by RT-qPCR and normalized to those of Oaz1. Relative gene expression in TECs from CV-B4 E2- vs. mock-infected thymuses was calculated, as described in , and expressed as 100 × mean 2 −ΔΔCt values ± SD. The unpaired t -test was used for statistical analysis. * p < 0.05, ** p < 0.01, *** p < 0.001. Mock (●) TECs from mock-infected thymuses harvested at different time points, from fetuses at day 17 of gestation (day 17G), and newborns at day 1 and day 5 from birth. CV-B4 10G (▼): TECs from thymus harvested from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (♦): thymus harvested from mice born to dams inoculated with CV-B4 at day 17 of gestation.
Article Snippet:
Techniques: Immunopeptidomics, Infection, Isolation, Quantitative RT-PCR, Gene Expression
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Transcription factors and autoantigens protein expression in the whole thymus. ( a ) Representative blots depicting the expression levels of AIRE, FEZF2, IGF2, and MYO7 proteins in CV-B4- and mock-infected thymus sampled at day 1. ( b ) Relative expression of AIRE, FEZF2, IGF2, and MYO7 determined by Western blot analysis. Proteins obtained from mock- and CV-B4-infected thymuses ( n = 3–5), harvested at different time-points, were submitted to AIRE, FEZF2, IGF2, and MYO7 quantification by Western-blot analysis. Proteins levels were normalized to those of VINCULIN used as a loading control. Relative protein levels in CV-B4 E2- vs. mock-infected thymuses are represented as mean ± SD. The unpaired t -test was used for statistical analysis. * p < 0.05. Mock (●): mock-infected thymuses harvested at different time points, from fetuses at day 17 of gestation (day 17G), and newborns at day 1 and day 5 from birth. CV-B4 10G (▼): thymus harvested from mice born to dams inoculated with CV-B4 at day 10 of gestation; CV-B4 17G (♦): thymus harvested from mice born to dams inoculated with CV-B4 at day 17 of gestation.
Article Snippet:
Techniques: Immunopeptidomics, Expressing, Infection, Western Blot, Control
Journal: Microorganisms
Article Title: Coxsackievirus B4 Transplacental Infection Severely Disturbs Central Tolerogenic Mechanisms in the Fetal Thymus
doi: 10.3390/microorganisms9071537
Figure Lengend Snippet: Relationship between viral load and transcription factors, Aire ( a ) and Fezf2 ( b ), and autoantigens transcripts, Igf2 ( c ) and Myo7 ( d ), in the thymus. For each harvested thymus (CV-B4-infected or age-matched control), transcription factors and autoantigens transcripts together with the corresponding viral load were measured and plotted in the same graph. To better assess the effect of infection on transcription factors and autoantigens expression, an eventual correlation between both parameters was evaluated using the Spearmen’s correlation test. r is the Spearman’s correlation coefficient. p -values were corrected according to the Benjamini–Hochberg procedure ( P BH ). Thymuses harvested at day 17G (Day 17G (10G) (●)), day 1 (Day 1 (10G) (▲)) or day 5 (Day 5 (10G) (♦)) from mice born to dams inoculated (or mock) with CV-B4 at day 10 of gestation; thymuses harvested at day 1 (Day 1 (17G) (▼)) or day 5 (Day 5 (17G) (■)) from mice born to dams inoculated (or mock) with CV-B4 at day 17 of gestation. x and y axis were log-scaled.
Article Snippet:
Techniques: Immunopeptidomics, Infection, Control, Expressing
Journal: International journal of molecular sciences
Article Title: SNHG15-Mediated Localization of Nucleolin at the Cell Protrusions Regulates CDH2 mRNA Expression and Cell Invasion.
doi: 10.3390/ijms242115600
Figure Lengend Snippet: Figure 2. IMP1 regulates the localization of SNHG15 at the cell protrusions. (A) FISH was per- formed to detect the subcellular localization of SNHG15 in WT BT-549 cells (upper panel) and SNHG15-expressing BT-549 cells (lower panel). The arrowheads indicate localized SNHG15 at the cell protrusions. Scale bar: 10 µm. (B) FISH indicated that, in comparison with WT MDA-MB-231 cells (upper panel), IMP1 expression greatly increased the localization of SHNG15 at cell protrusions (lower panel). Scale bar: 10 µm. (C) A bar graph indicates the percentage of protrusion-localized SNHG15 in tested cells. Localization was increased to 70% from 40% when ectopic IMP1 was ex- pressed. About 80–100 cells were counted in each group. ** p < 0.01. WT: cell origin. IMP1: cells expressing ectopic IMP1. Control: cells transfected with an empty plasmid. (D) RT-qPCR showed that IMP1 expression does not affect cellular levels of SNHG15.
Article Snippet:
Techniques: Expressing, Comparison, Control, Transfection, Plasmid Preparation, Quantitative RT-PCR
Journal: International journal of molecular sciences
Article Title: SNHG15-Mediated Localization of Nucleolin at the Cell Protrusions Regulates CDH2 mRNA Expression and Cell Invasion.
doi: 10.3390/ijms242115600
Figure Lengend Snippet: Figure 3. Localization of SNHG15 at the cell protrusions increases cell invasive potential. (A) The full-length SNHG15 and three dissected fragments of SNHG15 are separately tagged with six MS2 repeats. The relative position of the truncated SNHG15 is shown. The black box indicates the “ACACCC” motif for IMP1 binding. (B) FISH experiments showed that deletion of the “ACACCC” motif (Mut SNHG15) prevented SNHG15 from localizing at the cell protrusions. The arrowhead indicates cell-protrusion-localized SNHG15. Scale bar: 10 µm. (C) A bar graph shows that the cell population with protrusion-localized SNHG15 was largely decreased when the “ACACCC” motif was absent. ** p < 0.01. (D) Localization of the full-length and three truncated fragments of SNHG15 was determined by FISH. Results indicated that T1 and T3, but not T2, were still able to localize at the cell protrusions. About 80–100 cells were counted in each group. ** p < 0.01. (E) Transwell assays showed that, compared to the cells expressing full-length SNHG15, all three stable cell lines expressing truncated SNHG15 displayed lower invasive potentials. ** p < 0.01.
Article Snippet:
Techniques: Binding Assay, Expressing, Stable Transfection
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The primers and TaqMan probes of IGF, ER genes used for RT-PCR
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques:
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The mRNA levels of IGF-1, IGF-1R, IGF-2, IGF-2R, IGFBP-3, ERα and ERβ in EAC, tumor-adjacent, and control groups
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Control
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The immunostaining of IGF-1R, IGF-2R, ERα and ERβ in EAC, atypical hyperplasia, and control groups
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Immunostaining, Control, Positive Control
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The relationship between the IGF and ER mRNA expression and clinico-pathological features of endometrioid adenocarcinoma
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The relationship between the IGF-1R, IGF2R, ERα and ERβ protein expression and clinico-pathological features of endometrioid adenocarcinoma
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: Correlation analysis of IGF and ER mRNA expression with clinico-pathological features of EAC
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: Correlation analysis of IGF-1R, IGF-2R, and ERα and ERβ protein expression with clinico-pathological features of EAC
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing
Journal: BMC Cancer
Article Title: Insulin-like growth factors in endometrioid adenocarcinoma: Correlation with clinico-pathological features and estrogen receptor expression
doi: 10.1186/1471-2407-12-262
Figure Lengend Snippet: The analysis of the correlation between the mRNA expression of IGFs with ER subtypes in three groups
Article Snippet: Bio-engineering Co ., Ltd ., Wuhan , China),
Techniques: Expressing, Control
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: Schematic illustration of PTR-SeNPs and MUC1@PTR-SeNPs synthesis and their anti-tumor efficacy against human triple-negative breast cancer.
Article Snippet:
Techniques:
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: Structure characterization of PTR-SeNPs and MUC1@ PTR-SeNPs. Structure characterization of PTR-SeNPs by (A) TEM, (B) Zetasizer Nano ZS, (C, D) Nanosight NS300, (E1-4) HRTEM-EDS and (F, G) FT-IR. (H) Confirmation of MUC1-C + PTR-SeNPs conjugation by confocal microscopy after fluorescent labeling with anti-mouse IgG (H + L). (I, J) Characterization results of the particle size and potential of MUC1@PTR-SeNPs
Article Snippet:
Techniques: Conjugation Assay, Confocal Microscopy, Labeling
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: In vitro anti-tumor efficacy of PTR-SeNPs and MUC1@PTR-SeNPs on 17 TNBC c ell lines. ( A, B ) Protein expression level of MUC1 in 17 different TNBC cell lines. ( C, D ) IC 50 and maximum % growth inhibition of PTR-SeNPs and MUC1@PTR-SeNPs on 17 TNBC cell lines. ( E, G ) Cell cycle distribution triggered by PTR-SeNPs and MUC1@PTR-SeNPs in HCC1937 and MDA-MB-436 cells. After treatment with PTR-SeNPs or MUC1@PTR-SeNPs (4 and 40 μM) in HCC1937 and MDA-MB-436 cells for 72 h, cells were stained with propidium iodide followed by flow cytometry analysis using MultiCycle software. The apoptotic cell death was quantified by measuring the sub-G1 cell population. ( F, H ) Phosphatidylserine translocation mediated by PTR-SeNPs and MUC1@PTR-SeNPs in HCC1937 and MDA-MB-436 cells. After treatment with MUC1@PTR-SeNPs (4 and 40 μM) for 48 h, cells were co-stained with propidium iodide and Annexin-V-FITC followed by flow cytometry analysis [early apoptotic subset: Annexin V+/PI- (green); late apoptotic subset: Annexin V+/PT+ (red)].
Article Snippet:
Techniques: In Vitro, Expressing, Inhibition, Staining, Flow Cytometry, Software, Translocation Assay
Journal: Bioactive Materials
Article Title: Translational selenium nanoparticles trigger apoptosis in triple-negative breast cancer cells through the MAPKs/Bcl2 pathway
doi: 10.1016/j.bioactmat.2026.02.027
Figure Lengend Snippet: In vivo anti-tumor efficacy of MUC1@PTR- SeNPs. (A) MUC1 mRNA expression in normal tissue and primary breast cancer tumor using GEPIA database. ( B ) MUC1 expression in tumor tissues of MDA-MB-468-bearing mice in preliminary study. (C – E) Dose-dependent study of tumor inhibition effect of MUC1@PTR-SeNPs [75 (Low), 375 (Mid) & 750 μg (High) Se/kg BW/day] on BALB/c nude mice transplanted with MDA-MB-468 xenograft after oral administration for 30 days. PTR-SeNPs (High; 750 μg Se/kg BW/day) was used to investigate the possible improvement of in vivo anti-tumor efficacy by the MUC1@PTR-SeNPs. Quantitative analysis of Se content (μg/g) in (F) blood and (G) tumor tissue of experimental mice. (H) H&E, Ki67 and Tunnel fluorescence staining of tumor sections to detect apoptosis in vivo . (I) Western blot analysis of PARP, p-Bcl-2, Bax and C-caspase-9 protein expression in tumor sections. (J) In the serum of each group of tumor-bearing mice, the results of blood biochemistry-related indexes were analyzed.
Article Snippet:
Techniques: In Vivo, Expressing, Inhibition, Fluorescence, Staining, Western Blot
Journal: Translational Neurodegeneration
Article Title: Transplantation of hiPSC-derived pericytes rescues Alzheimer’s disease phenotypes in APOE 4/4 mice through IGF2-rich apoptotic vesicles
doi: 10.1186/s40035-025-00512-6
Figure Lengend Snippet: IGF2 in ApoVs plays a vital role in functional recovery of APOE 4/4-PCs in vitro. a ApoVs derived from APOE 3/3-PCs or HDFs were subjected to transcriptomic analysis and proteomic analysis. b Principal component analysis (PCA) evaluating the similarities of gene expression profiles between ApoVs −HDFs and ApoVs −PCs . c, d Volcano plot and heatmap of differential gene expression analysis between ApoVs −HDFs and ApoVs −PCs . e – h The differentially expressed genes were subjected to GO enrichment analysis. The GO terms related to neuron protection and cognition ( e ), blood–brain barrier maintenance ( f ), DNA replication and transcription ( g ) and cell growth and metabolic ( h ) were significantly enriched in ApoVs −PCs . i, j Volcano plot ( i ) and heatmap ( j ) of protein expression between ApoVs −HDFs and ApoVs −PCs . k, l qPCR and western blot analysis of IGF2 mRNA expression and protein level in ApoVs −HDFs and ApoVs −PCs . m, n IGF2 knockout in APOE 3/3-PCs using the CRISPR-Cas9 system. IGF2 expression was confirmed by western blot analysis. o, p Flow cytometry analysis with annexin V and PI staining revealed cell death rate in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). q Representative dextran leakage in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). r Representative Aβ transcytosis in APOE 3/3-PCs, APOE 4/4-PCs, APOE 4/4-PCs + ApoVs −PCs−IGF2KO and APOE 4/4-PCs + ApoVs −PCs−IGF2NC groups ( n = 3 biological repeats for each group). One-way ANOVA with Tukey’s multiple comparison test; ns, non-significant, * P < 0.05; ** P < 0.01; *** P < 0.001
Article Snippet: The primary antibodies were anti-Aβ 40 (Servicebio, Cat. #GB111197-100, 1:1000), Aβ1-42 Rabbit mAb (ABclonal, Cat. #A24422, 1:1000), phospho-tau-T181 rabbit mAb (ABclonal, Cat. #AP1387, 1:1000, Wuhan, China), and
Techniques: Functional Assay, In Vitro, Derivative Assay, Gene Expression, Expressing, Western Blot, Knock-Out, CRISPR, Flow Cytometry, Staining, Comparison